Real-time enrollment status for this sjogren's disease clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT06928142 |
| Recruiting Status | Recruiting |
| Condition | Sjogren's Disease |
| Phase | Clinical Trial |
| Target Enrollment | 80 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | January 21, 2026 (Jan 21, 2026) |
As of March 2, 2026: Clinical trial NCT06928142 is currently recruiting participants. This clinical trial study for sjogren's disease is actively seeking new participants at 18 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06928142 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06928142 was last updated Jan 21, 2026 (January 21, 2026). HelloStudys verifies this status automatically.